MARY KATHERINE KUSHNERICK: Open Payments
NPI 1124807912 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,980 in 91 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,632 · 2025 $1,980
Food & beverage: $1,980
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $368 |
| ABBVIE INC. | 18 | $297 |
| UCB, Inc. | 11 | $265 |
| AstraZeneca Pharmaceuticals LP | 11 | $262 |
| Janssen Biotech, Inc. | 8 | $191 |
| GlaxoSmithKline, LLC. | 7 | $172 |
| Novartis Pharmaceuticals Corporation | 5 | $127 |
| Radius Health, Inc. | 4 | $76 |
| ANI Pharmaceuticals, Inc. | 2 | $47 |
| Fresenius Kabi USA, LLC | 2 | $44 |
Products named: RINVOQ, SAPHNELO, Bimzelx, TREMFYA, BENLYSTA, EVENITY, COSENTYX, UPLIZNA.
Industry payments across PA — which companies pay providers there.
